Tag: melbourne
Recent Posts
- Resolution Minerals Secures White House FAST-41 Status for Antimony Ridge as Shares Surge Over 63% in a Single Day
- Morgan Stanley Launches First Bank-Issued Bitcoin ETF on a Day Bitcoin Surged 4.5%
- Is Palantir Stock Overvalued Despite Record Growth Numbers
- Wildcat Bolt Cutter Lithium System Expands With Strong Drilling Results
- WA Mining Conference and Exhibition 2026 Brings Industry Leaders to Perth This September
- Tesla Germany Sales Surge Jumps 315% in March 2026
- Orora Limited FY26 Trading Update: Middle East Impact
- Bendigo Bank Q3 Trading Update and New Partnerships
- Europe’s Carmakers Lead the Charge in Green Steel Transformation for 2026
- Apple iPhone Sales Surge Worldwide As Demand Stays Strong
- CoreWeave Stock (CRWV) Slides 42% In Six Months: Buy The Dip?
- CSL Share Price at $140: What the 2026 Forecast Really Says
- Flight Centre Secures $61.7m Pedal Group Exit as Independent Expert Approves Sale
- Bellevue Gold (ASX:BGL) March 2026 Quarterly Update
- Santos Alaska Appraisal Success Boosts Project Pipeline
- Pro Medicus Lands $23M US Health Deal
- Hours After Threatening to Wipe Out Iran, Trump Agreed to a Two-Week Ceasefire. Here’s What Changed.
- DroneShield’s Founding CEO Exits After 11 Years as the Company Posts Record Revenue
- US Gold Miners Secure Over $2 Billion in Financing Amid Rising Production Demand
- Star Copper Funding 2026 Drilling Gains Strong Backing
- Cannindah Resources Fires Up Diamond Drilling at Southern Porphyry Copper-Gold Target in a Potentially Transformational Move
- Capricorn Metals and Ramelius Resources Rise on Strong Quarterly Results
- NEXTDC Launches A$1 Billion Hybrid Securities Offer Backed by La Caisse
- St George Mining Strikes Record at Araxá: 178.7m of High-Grade Rare Earths and Niobium from Surface Cements World-Class Status
- Capricorn Metals March 2026 Production Update
- CSL Addresses US Pharmaceutical Tariff Changes
- BOQ Announces Capital Partnership with Challenger
- Volkswagen Recall Canada: Over 8,000 Vehicles Flagged for Instrument Cluster Safety Risk
- ASML Stock Eyes 20% Gain as EUV Dominance Powers Growth
- UBS Top 12 AI Stocks Highlight Strong Spending Momentum
Categories
Disclaimer
COLITCO LLP accepts no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. COLITCO LLP or an associate may receive a commission for funds raised.